Massachusetts Financial Services CO Co Diagnostics, Inc. Call Options Transaction History
Massachusetts Financial Services CO
- $314 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CODX
# of Institutions
50Shares Held
4.51MCall Options Held
3.3KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.39 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny587KShares$786,5800.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$672,7130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA317KShares$425,2890.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$365,6860.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $45.3M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...